Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 10 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ARIAD PHARMACEUTICALS INC | 61,000 | reported | 11 Apr 2008 | tx 3+166,000 |
| Conatus Pharmaceuticals Inc | 30,000 | reported | 30 Mar 2021 | tx 5+861,178 |
| ZEVRA THERAPEUTICS, INC. | 29,973 | reported | 09 Mar 2023 | tx 25+1,101,859 |
| NEXMED INC | 1,666 | reported | 04 Jan 2024 | tx 26+2,386,752−102,281 |
| Somaxon Pharmaceuticals, Inc. | 0 | reported | 06 Mar 2013 | tx 38+2,874,003−1,185,335 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 04 Jan 2024 | GRANT_AWARD | NEXMED INC | 1,666 | 0.00 USD | deriv |
| 09 Mar 2023 | PURCHASE | ZEVRA THERAPEUTICS, INC. | 10,000 | 4.20 USD | |
| 13 Jan 2023 | PURCHASE | ZEVRA THERAPEUTICS, INC. | 9,500 | 5.44 USD | |
| 09 Jan 2023 | GRANT_AWARD | ZEVRA THERAPEUTICS, INC. | 700,000 | 0.00 USD | deriv |
| 05 Jan 2023 | GRANT_AWARD | NEXMED INC | 50,000 | 0.00 USD | deriv |
| 18 May 2022 | PURCHASE | ZEVRA THERAPEUTICS, INC. | 300 | 4.90 USD | |
| 18 May 2022 | PURCHASE | ZEVRA THERAPEUTICS, INC. | 1,700 | 4.93 USD | |
| 18 May 2022 | PURCHASE | ZEVRA THERAPEUTICS, INC. | 100 | 4.90 USD | |
| 18 May 2022 | PURCHASE | ZEVRA THERAPEUTICS, INC. | 1,767 | 4.92 USD | |
| 18 May 2022 | PURCHASE | ZEVRA THERAPEUTICS, INC. | 400 | 4.91 USD | |
| 18 May 2022 | PURCHASE | ZEVRA THERAPEUTICS, INC. | 400 | 4.91 USD | |
| 18 May 2022 | PURCHASE | ZEVRA THERAPEUTICS, INC. | 333 | 4.94 USD | |
| 01 Feb 2022 | GRANT_AWARD | ZEVRA THERAPEUTICS, INC. | 127,286 | 0.00 USD | deriv |
| 05 Jan 2022 | GRANT_AWARD | NEXMED INC | 35,000 | 0.00 USD | deriv |
| 30 Nov 2021 | PURCHASE | ZEVRA THERAPEUTICS, INC. | 1,500 | 7.88 USD | |
| 10 Nov 2021 | GRANT_AWARD | ZEVRA THERAPEUTICS, INC. | 100,000 | 0.00 USD | deriv |
| 17 Jun 2021 | GRANT_AWARD | ZEVRA THERAPEUTICS, INC. | 15,000 | 0.00 USD | deriv |
| 30 Mar 2021 | PURCHASE | Conatus Pharmaceuticals Inc | 20,000 | 1.14 USD | |
| 13 Jan 2021 | GRANT_AWARD | Conatus Pharmaceuticals Inc | 346,000 | 0.00 USD | deriv |
| 06 Jan 2021 | GRANT_AWARD | NEXMED INC | 16,000 | 0.00 USD | deriv |
| 03 Dec 2020 | PURCHASE | Conatus Pharmaceuticals Inc | 10,000 | 1.24 USD | |
| 18 Aug 2020 | PURCHASE | ZEVRA THERAPEUTICS, INC. | 1,000 | 0.64 USD | |
| 18 Aug 2020 | PURCHASE | ZEVRA THERAPEUTICS, INC. | 1,800 | 0.64 USD | |
| 18 Aug 2020 | PURCHASE | ZEVRA THERAPEUTICS, INC. | 7,200 | 0.63 USD | first after silence |
| 19 Jun 2020 | GRANT_AWARD | ZEVRA THERAPEUTICS, INC. | 30,000 | 0.00 USD | deriv |
3 purchases reported after at least 12 months of silence — most recent on 18 Aug 2020.